<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02579889</url>
  </required_header>
  <id_info>
    <org_study_id>BA104</org_study_id>
    <nct_id>NCT02579889</nct_id>
  </id_info>
  <brief_title>Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease</brief_title>
  <acronym>B3</acronym>
  <official_title>Clinical Benefits of the Closed Loop Stimulation in Sinus Node Disease - B3 Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Biotronik SE &amp; Co. KG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Biotronik SE &amp; Co. KG</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is designed as a multi-center, international, prospective, parallel, randomized,
      single blinded trial comparing the time to first primary endpoint event (Sustained Paroxysmal
      AF/Persistent AF or stroke/TIA) occurrence in a follow up period of 3 years, between Closed
      Loop Stimulation (CLS) ON versus OFF, on top of a DDD pacing in patients with pacemaker or
      ICD indication who require dual-chamber pacing due to sinus node disease (SND), with or
      without atrioventricular (AV) block.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The benefits of rate-responsiveness on top of dual-chamber pacing still need to be
      definitively assessed in Sinus Node Dysfunction (SND). Although many rate responsive (RR)
      sensors have been developed, no large clinical trials evaluated their benefits in terms of
      clinical endpoints such as clinically relevant atrial fibrillation (AF) and stroke.
      Electromechanical sensors (piezoelectric accelerometers) have been widely used for their
      simplicity and overall reliability. However there is some evidence indicating the Closed Loop
      Stimulation as one of the more efficient and physiological sensors.

      Two randomized clinical studies have been conducted so far, showing that in the Brady-Tachy
      Syndrome the CLS algorithm was associated with a significantly lower overall atrial
      arrhythmia burden as compared both with a DDDR mode based on a standard accelerometric sensor
      and an atrial overdrive approach.

      Both studies yielded consistent results, albeit with a parallel and intraindividual
      comparison designs, respectively. The atrial arrhythmic burden is an important but surrogate
      endpoint, not necessarily related to long-term clinical outcome. The CLS effects on AF (if
      any) should be investigated in terms of time to first new onset of clinically relevant AF.

      In the light of these considerations, it appears interesting to run a large randomized study
      coherently collecting data on the overall clinical benefit of CLS, primarily in terms of AF
      and stroke, in a population indicated for pacemaker or ICD and needing dual-chamber pacing
      due to SND.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>First event of Sustained Paroxysmal AF or Persistent AF or stroke or TIA, whichever comes first.</measure>
    <time_frame>three years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustained Paroxysmal AF (SPAF)</measure>
    <time_frame>Three years</time_frame>
    <description>Assess the date of each events of SPAF occurred during the follow-up periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent AF</measure>
    <time_frame>Three years</time_frame>
    <description>Assess the date of each events of peristent AF occurred during the follow-up periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Permanent AF</measure>
    <time_frame>Three years</time_frame>
    <description>Assess the date when AF is declared permanent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stroke/TIA</measure>
    <time_frame>Three years</time_frame>
    <description>Assess the date of each events of stroke/TIA occurred during the follow-up periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Worsening Heart failure Hospitalization (wHF-H)</measure>
    <time_frame>Three years</time_frame>
    <description>Assess the date of each events of wHF-H occurred during the follow-up periods</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>Three years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1308</enrollment>
  <condition>Sinus Node Disease</condition>
  <arm_group>
    <arm_group_label>Active group - CLS ON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Device will be programmed in a dual-chamber DDD pacing mode with the Closed Loop Stimulation (CLS) function ON; Intervention: DDD+CLS</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group - CLS OFF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Device will be programmed in a dual-chamber DDD(R) pacing mode with the Closed Loop Stimulation (CLS) function OFF</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DDD+CLS</intervention_name>
    <description>Device will be programmed in a dual-chamber DDD pacing mode with the Closed Loop Stimulation (CLS) function ON</description>
    <arm_group_label>Active group - CLS ON</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DDD(R)</intervention_name>
    <description>Device will be programmed in a dual-chamber DDD(R) pacing mode with the Closed Loop Stimulation (CLS) function OFF</description>
    <arm_group_label>Control group - CLS OFF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Class I or II recommendations for permanent pacing due to SND, with or
             without AV block according to the current guidelines;

          -  Patients for whom dual-chamber pacing is indicated or preferred;

          -  Patients with an optimized and stable antiarrhythmic medical therapy at the time of
             enrolment;

          -  Closed Loop Stimulation function was not previously activated;

          -  No stroke events from implant;

          -  Patient implanted for the first time;

        Exclusion Criteria:

          -  Permanent AF (PermAF)

          -  NYHA Class IV Heart Failure

          -  Stage V kidney dysfunction

          -  Any indication to Cardiac Resynchronization Therapy (CRT)

          -  Life expectancy &lt; 1

          -  Minors

          -  Pregnant or breast-feeding patients

          -  Participation in another interventional trial

          -  Atrial fibrillation ablation (left pulmonary veins) or other cardiac surgery &lt; 3 m
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nicola Rovai</last_name>
    <email>nicola.rovai@biotronik.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alessio Gargaro</last_name>
    <email>alessio.gargaro@biotronik.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Ospedale &quot;Bolognini&quot;</name>
      <address>
        <city>Seriate</city>
        <state>Bergamo</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alessandro Locatelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno Casiraghi</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Bolognini</name>
      <address>
        <city>Seriate</city>
        <state>Bergamo</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Alessandro Locatelli</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Presidio Ospedaliero Ospedale Sant'Anna</name>
      <address>
        <city>San Fermo della Battaglia</city>
        <state>Como</state>
        <zip>22020</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gianluca Botto</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale F. Ferrari</name>
      <address>
        <city>Casarano</city>
        <state>Lecce</state>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Donato Melissano</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Policlinico Consorziale</name>
      <address>
        <city>Bari</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Domenico Carretta</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Caserta Sant'Anna e San Sebastiano</name>
      <address>
        <city>Caserta</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Miguel Viscusi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U. Policlinico Vittorio Emanuele</name>
      <address>
        <city>Catania</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valeria Calvi</last_name>
      <email>valcalcvi@unict.it</email>
    </contact>
    <investigator>
      <last_name>Valeria Calvi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Fabrizio Spaziani</name>
      <address>
        <city>Frosinone</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Luigi Carbonardi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST Valle Olona - Ospedale Sant'Antonio Abate</name>
      <address>
        <city>Gallarate</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ivan Caico</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ASST RHODENSE - Ospedale Guido Salvini</name>
      <address>
        <city>Garbagnate</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Fabio Locati</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale Vito Fazzi</name>
      <address>
        <city>Lecce</city>
        <zip>73100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Ennio Carmine Pisanò</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nuovo Ospedale delle Apuane</name>
      <address>
        <city>Massa</city>
        <zip>54100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Giuseppe Arena</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Vincenzo Borrello</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Cardiologico Monzino</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Vittoria Marino</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.P. Federico II</name>
      <address>
        <city>Napoli</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Antonio Rapacciuolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>A.O.U Maggiore della Carità di Novara</name>
      <address>
        <city>Novara</city>
        <zip>28100</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Eraldo Occhetta</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriele Dell'Era</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera di Padova</name>
      <address>
        <city>Padova</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Emanuele Bertaglia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ospedale S. Maria della Misericordia</name>
      <address>
        <city>Perugia</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gianluca Zingarini</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli</name>
      <address>
        <city>Rom</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Gemma Pelargonio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario de Alicante</name>
      <address>
        <city>Alicante</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Juan Gabriel Martinez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Puglisi A, Altamura G, Capestro F, Castaldi B, Critelli G, Favale S, Pavia L, Pettinati G. Impact of Closed-Loop Stimulation, overdrive pacing, DDDR pacing mode on atrial tachyarrhythmia burden in Brady-Tachy Syndrome. A randomized study. Eur Heart J. 2003 Nov;24(21):1952-61.</citation>
    <PMID>14585254</PMID>
  </results_reference>
  <results_reference>
    <citation>Puglisi A, Favale S, Scipione P, Melissano D, Pavia L, Ascani F, Elia M, Scaccia A, Sagone A, Castaldi B, Musacchio E, Botto GL; Burden II Study Group. Overdrive versus conventional or closed-loop rate modulation pacing in the prevention of atrial tachyarrhythmias in Brady-Tachy syndrome: on behalf of the Burden II Study Group. Pacing Clin Electrophysiol. 2008 Nov;31(11):1443-55. doi: 10.1111/j.1540-8159.2008.01208.x.</citation>
    <PMID>18950302</PMID>
  </results_reference>
  <results_reference>
    <citation>Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, Morillo CA, Carlson M, Themeles E, Kaufman ES, Hohnloser SH; ASSERT Investigators. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012 Jan 12;366(2):120-9. doi: 10.1056/NEJMoa1105575. Erratum in: N Engl J Med. 2016 Mar 10;374(10):998.</citation>
    <PMID>22236222</PMID>
  </results_reference>
  <results_reference>
    <citation>Russo V, Rago A, Papa AA, Golino P, Calabrò R, Russo MG, Nigro G. The effect of dual-chamber closed-loop stimulation on syncope recurrence in healthy patients with tilt-induced vasovagal cardioinhibitory syncope: a prospective, randomised, single-blind, crossover study. Heart. 2013 Nov;99(21):1609-13. doi: 10.1136/heartjnl-2013-303878. Epub 2013 May 30.</citation>
    <PMID>23723446</PMID>
  </results_reference>
  <results_reference>
    <citation>de Cock CC, Giudici MC, Twisk JW. Comparison of the haemodynamic effects of right ventricular outflow-tract pacing with right ventricular apex pacing: a quantitative review. Europace. 2003 Jul;5(3):275-8. Review.</citation>
    <PMID>12842643</PMID>
  </results_reference>
  <results_reference>
    <citation>Lieberman R, Grenz D, Mond HG, Gammage MD. Selective site pacing: defining and reaching the selected site. Pacing Clin Electrophysiol. 2004 Jun;27(6 Pt 2):883-6.</citation>
    <PMID>15189520</PMID>
  </results_reference>
  <results_reference>
    <citation>Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav EJ, Hellkamp AS, Greer S, McAnulty J, Ellenbogen K, Ehlert F, Freedman RA, Estes NA 3rd, Greenspon A, Goldman L; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med. 2002 Jun 13;346(24):1854-62.</citation>
    <PMID>12063369</PMID>
  </results_reference>
  <results_reference>
    <citation>Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, Sami MH, Talajic M, Tang AS, Klein GJ, Lau C, Newman DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med. 2000 May 11;342(19):1385-91.</citation>
    <PMID>10805823</PMID>
  </results_reference>
  <results_reference>
    <citation>Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events Trial Investigators. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med. 2005 Jul 14;353(2):145-55.</citation>
    <PMID>16014884</PMID>
  </results_reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 16, 2015</study_first_submitted>
  <study_first_submitted_qc>October 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 20, 2015</study_first_posted>
  <last_update_submitted>March 8, 2017</last_update_submitted>
  <last_update_submitted_qc>March 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Closed Loop Stimulation</keyword>
  <keyword>Atrial Fibrillation</keyword>
  <keyword>Stroke</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Pacemaker</keyword>
  <keyword>ICD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

